Enanta Pharmaceuticals
ENTA
#7451
Rank
A$0.63 B
Marketcap
A$21.98
Share price
3.62%
Change (1 day)
75.84%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -A$0.14 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are A$64.8 Million. In 2024 the company made an earning of -A$0.15 Billion, an increase over its 2023 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.14 Billion-9.14%
2024 -A$0.15 Billion-23.87%
2023 -A$0.2 Billion4.39%
2022 -A$0.19 Billion-4.4%
2021 -A$0.2 Billion91.12%
2020 -A$0.11 Billion-407.13%
2019 A$32.74 M-78.63%
2018 A$0.15 B117.97%
2017 A$70.31 M-574.65%
2016 -A$14.82 Million-110.83%
2015 A$0.13 B-4.5%
2014 A$0.14 B-638.53%
2013 -A$26.61 Million-137.98%
2012 A$70.03 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
A$2.49 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.71 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.76 B-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.09 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$24.71 B-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland